Inactive Instrument

Acarix AB (publ) Stock price Nasdaq Stockholm

Equities

SE0009268717

Advanced Medical Equipment & Technology

Sales 2023 6.24M 585K Sales 2024 * 86.9M 8.15M Capitalization 190M 17.83M
Net income 2023 -77M -7.22M Net income 2024 * -24M -2.25M EV / Sales 2023 22.4 x
Net cash position 2023 * - 0 Net cash position 2024 * - 0 EV / Sales 2024 * 2.19 x
P/E ratio 2023
-1.19 x
P/E ratio 2024 *
-
Employees -
Yield 2023 *
-
Yield 2024 *
-
Free-Float 88.07%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Acarix AB (publ)

Managers TitleAgeSince
Founder 60 06-12-31
Director of Finance/CFO 60 15-12-31
Chief Tech/Sci/R&D Officer 47 21-12-31
Members of the board TitleAgeSince
Chairman 51 21-05-10
Director/Board Member 64 13-12-31
Director/Board Member 70 21-05-10
More insiders
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company's primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Calendar
More about the company
  1. Stock
  2. Equities
  3. Stock Acarix AB
  4. Stock Acarix AB (publ) - Nasdaq Stockholm